Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy
- PMID: 2587044
- DOI: 10.1016/s0161-6420(89)32700-x
Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy
Abstract
The authors reviewed the medical records of 191 patients (232 eyes) who underwent closed vitrectomy for complications of diabetic retinopathy to evaluate the clinical picture of postvitrectomy hemorrhage (PVH). One hundred thirty-nine eyes (59.9%) had at least one episode of PVH (average, 1.5 per eye) that was variable in onset, not associated with a known cause in four fifths, with no noted source in two thirds, and severe in three fourths of the cases. Using logistic regression statistical analyses, the factors significantly associated with decreased incidence of PVH include older age of patient (P = 0.0004), long duration of surgery (P = 0.0002), and poor preoperative vision (P = 0.05). Of the 139 eyes with PVH, 65 (47%) had spontaneous clearing in an average of 11.3 weeks, 53 (38%) required repeat surgery, and 21 (15%) were inoperable, lost to follow-up, or refused reoperation. Postvitrectomy hemorrhage did not significantly influence the final visual outcome.
Similar articles
-
Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):665-671. doi: 10.1007/s00417-016-3522-8. Epub 2016 Oct 21. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27770210
-
Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.Curr Eye Res. 2010 Apr;35(4):308-13. doi: 10.3109/02713680903572491. Curr Eye Res. 2010. PMID: 20373898
-
Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.Am J Ophthalmol. 1998 Jul;126(1):82-90. doi: 10.1016/s0002-9394(98)00066-x. Am J Ophthalmol. 1998. PMID: 9683153
-
Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications.Retina. 1991;11(3):309-14. doi: 10.1097/00006982-199111030-00007. Retina. 1991. PMID: 1961989
-
Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group.Ophthalmology. 1995 May;102(5):705-12. doi: 10.1016/s0161-6420(95)30965-7. Ophthalmology. 1995. PMID: 7777268 Review.
Cited by
-
The use of antivascular endothelial growth factor agents in the perioperative period in diabetic vitrectomy.Middle East Afr J Ophthalmol. 2012 Jan;19(1):83-7. doi: 10.4103/0974-9233.92120. Middle East Afr J Ophthalmol. 2012. PMID: 22346119 Free PMC article.
-
Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.Int Ophthalmol. 2010 Apr;30(2):137-42. doi: 10.1007/s10792-009-9298-7. Epub 2009 Jan 25. Int Ophthalmol. 2010. PMID: 19169862
-
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 May 31;5:CD008214. doi: 10.1002/14651858.CD008214.pub4. PMID: 26250103 Free PMC article. Updated.
-
Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy.Pak J Med Sci. 2013 Apr;29(2):590-2. doi: 10.12669/pjms.292.3044. Pak J Med Sci. 2013. PMID: 24353583 Free PMC article.
-
The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.BMC Ophthalmol. 2020 Feb 3;20(1):43. doi: 10.1186/s12886-020-1321-9. BMC Ophthalmol. 2020. PMID: 32013913 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical